DiscGenics Raises $50 Million in Series C Funding

DiscGenics announced it has raised $50 million in Series C funding led by Ci:z Investment LLP with participation from new investors including Eagle Fund SP1 LLP, Medical Incubator Japan and CareNet of Japan. This round of funding brings the company to just over $71 million to-date.

Discgenics will use the capital to support ongoing...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us